Literature DB >> 12034108

QS-21 structure/function studies: effect of acylation on adjuvant activity.

Gui Liu1, Christine Anderson, Heidi Scaltreto, Jeffrey Barbon, Charlotte R Kensil.   

Abstract

QS-21 is a natural saponin adjuvant derived from the tree Quillaja saponaria Molina. Previous studies over a limited dose range suggested the acylation is critical to adjuvant activity. In this study, we prepared DS-1 (deacylated QS-21) and RDS-1 (reacylated DS-1 with dodecylamine at a different site than QS-21) to determine the effect on a dose-response curve over a wider range in mice. DS-1 and RDS-1 induced IgG1 responses at higher doses compared to that induced by QS-21. DS-1 was inactive for inducing IgG2a or CTL responses at any doses. RDS-1 showed moderate IgG2a response at 240 microg, but did not show CTL response at any dose evaluated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034108     DOI: 10.1016/s0264-410x(02)00209-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

Review 1.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

2.  Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice.

Authors:  Samaneh H Shabani; Sedigheh Zakeri; Yousef Mortazavi; Akram A Mehrizi
Journal:  Med Microbiol Immunol       Date:  2019-04-25       Impact factor: 3.402

3.  Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide.

Authors:  Pengfei Wang; Dattatray A Devalankar; Qipu Dai; Ping Zhang; Suzanne M Michalek
Journal:  J Org Chem       Date:  2016-10-13       Impact factor: 4.354

Review 4.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 5.  Adjuvant effects of saponins on animal immune responses.

Authors:  Zahid Iqbal Rajput; Song-hua Hu; Chen-wen Xiao; Abdullah G Arijo
Journal:  J Zhejiang Univ Sci B       Date:  2007-03       Impact factor: 3.066

6.  Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.

Authors:  Elisabetta Bianchi; Xiaoping Liang; Paolo Ingallinella; Marco Finotto; Michael A Chastain; Jiang Fan; Tong-Ming Fu; Hong Chang Song; Melanie S Horton; Daniel C Freed; Walter Manger; Emily Wen; Li Shi; Roxana Ionescu; Colleen Price; Marc Wenger; Emilio A Emini; Riccardo Cortese; Gennaro Ciliberto; John W Shiver; Antonello Pessi
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.

Authors:  David Y Gin; Susan F Slovin
Journal:  Curr Drug ther       Date:  2011-08

8.  Design and synthesis of potent Quillaja saponin vaccine adjuvants.

Authors:  Michelle M Adams; Payal Damani; Nicholas R Perl; Annie Won; Feng Hong; Philip O Livingston; Govind Ragupathi; David Y Gin
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

9.  Synthesis of QS-21-based immunoadjuvants.

Authors:  Pengfei Wang; Qipu Dai; Punith Thogaripally; Ping Zhang; Suzanne M Michalek
Journal:  J Org Chem       Date:  2013-11-05       Impact factor: 4.354

10.  Vaccine Adjuvants Derivatized from Momordica Saponins I and II.

Authors:  Pengfei Wang; Xiong Ding; Hyunjung Kim; Đani Škalamera; Suzanne M Michalek; Ping Zhang
Journal:  J Med Chem       Date:  2019-10-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.